Back

Visualising Cholesterol in Brain by On-Tissue Derivatisation and Quantitative Mass Spectrometry Imaging

Angelini, R.; Yutuc, E.; Wyatt, M. F.; Newton, J.; Yusuf, F. A.; Griffiths, L.; Cooze, B. J.; El Assad, D.; Frache, G.; Rao, W.; Allen, L. B.; Korade, Z.; Nguyen, T. T.; Rathnayake, R. A.; Cologna, S. M.; Howell, O. W.; Clench, M. R.; Wang, Y.; Griffiths, W. J.

2020-11-07 biochemistry
10.1101/2020.11.06.369447 bioRxiv
Show abstract

Despite being a critical molecule for neurobiology and brain health, mass spectrometry imaging (MSI) of cholesterol has been under reported compared to other lipids, due to the difficulty in ionising the sterol molecule. In the present work we have employed an on-tissue enzyme-assisted derivatisation strategy to improve detection of cholesterol in brain tissue sections. We report distribution and levels of cholesterol across specific brain structures of the mouse brain, in a model of Niemann-Pick type C1 (NPC1) disease, and during brain development. MSI revealed how cholesterol changes during development and that in the adult is highest in pons and medulla of the brain stem. Cholesterol was significantly reduced in the corpus callosum and other brain regions in the Npc1 null mouse, confirming hypomyelination at the molecular level. Our study demonstrates the potential of MSI to the study of sterols in neuroscience.

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.